Jove
Visualize
Contact Us

Related Concept Videos

Repressed Memory01:16

Repressed Memory

506
Repressed memories are a psychological phenomenon where memories of traumatic events are unconsciously blocked from a person's awareness. This process occurs as a defense mechanism, protecting the mind from the emotional impact of distressing or painful experiences. For example, a person who has experienced childhood trauma may grow up with no conscious recollection of the event. In such cases, the memories are thought to be buried deep within the subconscious, inaccessible to the conscious...
506
Autophagy01:27

Autophagy

5.7K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.7K
Repressible Operon: trp Operon01:21

Repressible Operon: trp Operon

1.4K
The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
1.4K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
Hepatic Portal System01:21

Hepatic Portal System

5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Nature medicine·2026
Same author

Hierarchical endpoints and win statistics for geromedicine trials.

Nature aging·2026
Same author

Cell stress and death liberate the autophagy-inhibitory tissue stress hormone DBI/ACBP into the circulation.

Autophagy·2026
Same author

Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions.

Journal for immunotherapy of cancer·2026
Same author

Cell death-induced release of the pro-aging protein acyl CoA binding protein (ACBP) into the circulation.

Cell death and differentiation·2026
Same author

Spermine is an endogenous iron chelator that inhibits ferroptosis.

Nature·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 23, 2026

Activating Autophagy by Aerobic Exercise in Mice
08:44

Activating Autophagy by Aerobic Exercise in Mice

Published on: February 3, 2017

12.7K

Autophagy represses hepatic carcinogenesis.

Juliette Paillet1,2,3,4,5,6, Guido Kroemer1,2,3,4,5,7,8,9

  • 1Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.

Molecular & Cellular Oncology
|June 19, 2019
PubMed
Summary

Deleting the autophagy gene Autophagy-related 7 (Atg7) in liver cells triggers liver cancer. This occurs through the overactivation of YAP, a protein regulated by autophagy, leading to liver disease and cancer.

Keywords:
Age-related diseaseNK cellscytotoxic T cellsimmunosenescencesenescence

More Related Videos

Live Cell Imaging of Early Autophagy Events: Omegasomes and Beyond
09:00

Live Cell Imaging of Early Autophagy Events: Omegasomes and Beyond

Published on: July 27, 2013

19.2K
Methanol Independent Expression by Pichia Pastoris Employing De-repression Technologies
05:30

Methanol Independent Expression by Pichia Pastoris Employing De-repression Technologies

Published on: January 23, 2019

14.4K

Related Experiment Videos

Last Updated: Jan 23, 2026

Activating Autophagy by Aerobic Exercise in Mice
08:44

Activating Autophagy by Aerobic Exercise in Mice

Published on: February 3, 2017

12.7K
Live Cell Imaging of Early Autophagy Events: Omegasomes and Beyond
09:00

Live Cell Imaging of Early Autophagy Events: Omegasomes and Beyond

Published on: July 27, 2013

19.2K
Methanol Independent Expression by Pichia Pastoris Employing De-repression Technologies
05:30

Methanol Independent Expression by Pichia Pastoris Employing De-repression Technologies

Published on: January 23, 2019

14.4K

Area of Science:

  • Hepatology
  • Molecular Biology
  • Cancer Research

Background:

  • Autophagy is crucial for maintaining liver health.
  • Autophagy-related 7 (Atg7) is an essential gene for autophagy.
  • Loss of Atg7 in hepatocytes can lead to liver disease and cancer.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which Atg7 deficiency causes liver cancer.
  • To identify the role of YAP in Atg7-deficient hepatocarcinogenesis.

Main Methods:

  • Hepatocyte-specific knockout of Atg7 in mice.
  • Analysis of molecular pathways involved in liver cell proliferation and transformation.
  • Transcriptional profiling of Atg7-deficient hepatocytes.

Main Results:

  • Hepatocyte-specific Atg7 knockout induces liver hypertrophy, hyperplasia, and malignant transformation.
  • YAP, an autophagy substrate, is overactivated in Atg7-deficient hepatocytes.
  • Transcriptional changes in Atg7-deficient livers mimic non-alcoholic steatohepatitis (NASH) and steatohepatitic hepatocellular carcinoma (HCC).

Conclusions:

  • Autophagy, mediated by Atg7, is essential for preventing liver cancer.
  • YAP overactivation is a key event in Atg7-deficient hepatocarcinogenesis.
  • The study reveals a novel pathway linking impaired autophagy to liver disease and cancer, with implications for NASH and HCC.